Crinetics Pharmaceuticals Inc. (CRNX)
NASDAQ · Healthcare
Crinetics Pharmaceuticals Inc. Net Income 2016–2025
Crinetics Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2016 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Crinetics Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -127.8 M, a 32.11% increase year-over-year.
- Crinetics Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -470.3 M, a 70.87% increase year-over-year.
- Crinetics Pharmaceuticals Inc. annual net income for 2025 was -465.3 M, a 55.93% increase from 2024.
- Crinetics Pharmaceuticals Inc. annual net income for 2024 was -298.4 M, a 39.10% increase from 2023.
- Crinetics Pharmaceuticals Inc. annual net income for 2023 was -214.5 M, a 30.88% increase from 2022.
- Crinetics Pharmaceuticals Inc. annual net income for 2022 was -163.9 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Crinetics Pharmaceuticals Inc. Net Income — FAQ
Crinetics Pharmaceuticals Inc. (CRNX) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Crinetics Pharmaceuticals Inc.'s net income?
Crinetics Pharmaceuticals Inc. (CRNX) reported net income of -$465M for fiscal 2025.
Where can I see CRNX's net income history?
The chart and table above show Crinetics Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.